BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25407584)

  • 1. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis.
    Cuijpers P; Weitz E; Twisk J; Kuehner C; Cristea I; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Faramarzi M; Hegerl U; Jarrett RB; Kennedy SH; Kheirkhah F; Mergl R; Miranda J; Mohr DC; Segal ZV; Siddique J; Simons AD; Vittengl JR; Hollon SD
    Depress Anxiety; 2014 Nov; 31(11):941-51. PubMed ID: 25407584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
    Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
    JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
    Roshanaei-Moghaddam B; Pauly MC; Atkins DC; Baldwin SA; Stein MB; Roy-Byrne P
    Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
    Vittengl JR; Jarrett RB; Weitz E; Hollon SD; Twisk J; Cristea I; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Faramarzi M; Hegerl U; Kennedy SH; Kheirkhah F; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Cuijpers P
    Am J Psychiatry; 2016 May; 173(5):481-90. PubMed ID: 26869246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression.
    Cuijpers P; Weitz E; Lamers F; Penninx BW; Twisk J; DeRubeis RJ; Dimidjian S; Dunlop BW; Jarrett RB; Segal ZV; Hollon SD
    Depress Anxiety; 2017 Mar; 34(3):246-256. PubMed ID: 27921338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
    Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
    Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
    Barber JP; Barrett MS; Gallop R; Rynn MA; Rickels K
    J Clin Psychiatry; 2012 Jan; 73(1):66-73. PubMed ID: 22152401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
    Thase ME; Friedman ES; Fasiczka AL; Berman SR; Frank E; Nofzinger EA; Reynolds CF
    J Clin Psychiatry; 2000 Jul; 61(7):466-72. PubMed ID: 10937603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual patient data meta-analysis of combined treatments versus psychotherapy (with or without pill placebo), pharmacotherapy or pill placebo for adult depression: a protocol.
    Weitz E; Kleiboer A; van Straten A; Hollon SD; Cuijpers P
    BMJ Open; 2017 Feb; 7(2):e013478. PubMed ID: 28193851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the cognitive mediational model of cognitive behavioural therapy for depression.
    Quilty LC; McBride C; Bagby RM
    Psychol Med; 2008 Nov; 38(11):1531-41. PubMed ID: 18578895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-criticism predicts differential response to treatment for major depression.
    Marshall MB; Zuroff DC; McBride C; Bagby RM
    J Clin Psychol; 2008 Mar; 64(3):231-44. PubMed ID: 18302208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of cognitive behaviour therapy vs treatment as usual in the treatment of mild to moderate late life depression.
    Laidlaw K; Davidson K; Toner H; Jackson G; Clark S; Law J; Howley M; Bowie G; Connery H; Cross S
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):843-50. PubMed ID: 18311844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.
    Pinquart M; Duberstein PR; Lyness JM
    Am J Psychiatry; 2006 Sep; 163(9):1493-501. PubMed ID: 16946172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Depression Treatment Response in an Intensive CBT Partial Hospital.
    Beard C; Stein AT; Hearon BA; Lee J; Hsu KJ; Björgvinsson T
    J Clin Psychol; 2016 Apr; 72(4):297-310. PubMed ID: 26934333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.